Immediate Impact

66 standout
Sub-graph 1 of 24

Citing Papers

Heterogeneity and treatment landscape of ovarian carcinoma
2023 Standout
Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
2023 Standout
3 intermediate papers

Works of T. Akrivos being referenced

Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer
2009
Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study
2008

Author Peers

Author Last Decade Papers Cites
T. Akrivos 118 109 103 121 19 345
Maurizio Levorato 53 75 121 71 27 406
Paraskevi Tseke 41 32 108 59 18 319
Knut E. Kjørstad 110 141 77 65 23 347
Laura Rivoli 29 30 59 40 20 327
Nasir Sıvrı 23 27 128 45 17 354
Bahattin Adam 10 42 60 83 24 373
E R T C Owen 61 51 217 47 15 348
Hakkı Yılmaz 6 75 57 82 22 388
Thierry Roth 143 129 163 23 17 334
Jakob Hinrichs 45 15 341 28 17 377

All Works

Loading papers...

Rankless by CCL
2026